These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 20298966)

  • 1. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
    Tan CS; Koralnik IJ
    Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
    Bauer J; Gold R; Adams O; Lassmann H
    Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy.
    Weissert R
    J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression increases latent infection of brain by JC polyomavirus.
    Bayliss J; Karasoulos T; Bowden S; Glogowski I; McLean CA
    Pathology; 2011 Jun; 43(4):362-7. PubMed ID: 21532525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leukoencephalopathy.
    Sweeney BJ; Manji H; Miller RF; Harrison MJ; Gray F; Scaravilli F
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):994-7. PubMed ID: 8057128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy: clinical description and demonstration of the causal agent.
    Carrada-Bravo T
    Neurologia; 2005 Oct; 20(8):422-5. PubMed ID: 16220408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human JC polyomavirus (JCPyV): virological background and clinical implications.
    Hirsch HH; Kardas P; Kranz D; Leboeuf C
    APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JC virus granule cell neuronopathy in a child with CD40 ligand deficiency.
    Hecht JH; Glenn OA; Wara DW; Wu YW
    Pediatr Neurol; 2007 Mar; 36(3):186-9. PubMed ID: 17352955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of progressive multifocal leukoencephalopathy under biological agents used in the treatment of chronic inflammatory diseases.
    Toussirot É; Bereau M
    Inflamm Allergy Drug Targets; 2014; 13(2):121-7. PubMed ID: 24559124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.
    Sabath BF; Major EO
    J Infect Dis; 2002 Dec; 186 Suppl 2():S180-6. PubMed ID: 12424695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
    Travasarou M; Marousi S; Papageorgiou E; Karageorgiou CE
    Clin Neurol Neurosurg; 2013 Jun; 115(6):827-9. PubMed ID: 22920632
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies.
    Major EO
    Annu Rev Med; 2010; 61():35-47. PubMed ID: 19719397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of plasma exchange on serum anti-JC virus antibodies.
    Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
    Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?
    Koralnik IJ
    Ann Neurol; 2006 Aug; 60(2):162-73. PubMed ID: 16862584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoma nephropathy and progressive multifocal leukoencephalopathy in a renal transplant recipient.
    Phillips T; Jacobs R; Ellis EN
    J Child Neurol; 2004 Apr; 19(4):301-4. PubMed ID: 15163098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
    Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
    Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy: new concepts.
    Lima MA
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
    Harypursat V; Zhou Y; Tang S; Chen Y
    AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies and progressive multifocal leukoencephalopathy.
    Berger JR; Houff SA; Major EO
    MAbs; 2009; 1(6):583-9. PubMed ID: 20073129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
    Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
    J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.